Schisandrin B attenuates epidural fibrosis in postlaminectomy rats by inhibiting proliferation and extracellular matrix production of fibroblasts. (22nd October 2018)
- Record Type:
- Journal Article
- Title:
- Schisandrin B attenuates epidural fibrosis in postlaminectomy rats by inhibiting proliferation and extracellular matrix production of fibroblasts. (22nd October 2018)
- Main Title:
- Schisandrin B attenuates epidural fibrosis in postlaminectomy rats by inhibiting proliferation and extracellular matrix production of fibroblasts
- Authors:
- Jin, Haiming
Wang, Zhen
Gu, Zenan
Wu, Jianwei
Bai, Xueqin
Shao, Zhenxuan
Miao, Jiansen
Wang, Qingqing
Wang, Quan
Wang, Xiangyang - Abstract:
- Abstract : Laminectomy has been widely considered one of the most common treatments for lumbar disorders. Epidural fibrosis (EF) is a common complication after laminectomy, causing recurrent postoperative pain. Schisandrin B (Sch.B), the active ingredient extracted from Schisandra chinensis Fructus, has been found to have potent antiproliferative and antifibrotic effects on several cells. This study aimed to investigate the effects of Sch.B on the prevention of postlaminectomy EF formation. In vitro, we studied the effects of Sch.B on transforming growth factor beta 1 (TGF‐β1)‐induced proliferation and extracellular matrix (ECM) production of primary fibroblasts, as well as its underlying mechanism. We found that Sch.B not only inhibited the proliferation of fibroblasts but also reduced ECM production, including that of connective tissue growth factor, fibronectin, and type I collagen, in a dose‐dependent manner. Mechanistically, we found that Sch.B suppressed TGF‐β1‐stimulated activation of the Smad2/3 and mitogen‐activated protein kinase pathways. Moreover, the in vivo study demonstrated that Sch.B treatment attenuated the progression of EF in a postlaminectomy rat model via reducing the cell number and ECM production of scar tissue. Taken together, these data suggested that Sch.B possesses great potential value as a preventative agent for EF.
- Is Part Of:
- Phytotherapy research. Volume 33:Number 1(2019)
- Journal:
- Phytotherapy research
- Issue:
- Volume 33:Number 1(2019)
- Issue Display:
- Volume 33, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 33
- Issue:
- 1
- Issue Sort Value:
- 2019-0033-0001-0000
- Page Start:
- 107
- Page End:
- 116
- Publication Date:
- 2018-10-22
- Subjects:
- epidural fibrosis -- fibroblast -- MAPK -- Schisandrin B -- Smad2/3 -- TGF‐β1
Materia medica, Vegetable -- Periodicals
Botany, Medical -- Periodicals
Medicinal plants -- Periodicals
Plant Extracts -- therapeutic use -- Periodicals
Plants, Medicinal -- Periodicals
581.634 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/ptr.6204 ↗
- Languages:
- English
- ISSNs:
- 0951-418X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6497.060000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22192.xml